ArticleCell death & disease2015

Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.

N Werthmöller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.